Testicular cancer is a malignant tumor that originates in the male reproductive organs called the testes. The testes create sperm and produce the hormone testosterone. Testicular cancer is not common compared to other types of cancer, but it is the most frequent solid tumor that affects adolescent and young adult males, especially those aged 15 to 40 years.
The key point about testicular cancer is that doctors can treat it successfully, while many patients achieve complete recovery from the disease, which starts as advanced cancer. The medical field has improved survival rates through early cancer detection, precise cancer staging, and personalized cancer treatment based on patient risk levels over the past 30 years.
Most cases of testicular cancer are caused by germ cells, which produce sperm. The medical community refers to these tumors as testicular germ cell tumors based on this scientific fact.
The medical field categorizes testicular cancers into two key diagnostic groups:
Seminomas display slow-growing characteristics but are responsive to treatment methods involving chemotherapy and radiotherapy. They are known to affect men aged 30 to 50.
This type of cancer is aggressive. It is mostly prevalent in young males. The types include:
Mixed tumors that contain multiple histological types occur frequently in medical practice. The testis has rare non-germ cell tumors, which include stromal tumors, but Leydig cell tumors constitute the most common type of testicular stromal tumors.
Researchers have not yet explored the precise cause of testicular cancer. Germ cells begin to multiply uncontrollably, which leads to cancer development. The established risk factors include:
Many men who receive a testicular cancer diagnosis display no identifiable risk factors.
The most typical initial symptom is a painless lump or swelling in one testicle. The condition may present with various additional symptoms, which include:
The absence of pain means people need to perform self-exams regularly so they can discover health issues at an early stage.
A clinical exam may reveal a firm, non-tender mass within the testis.
The primary imaging test for scrotal ultrasound helps doctors identify solid tumors and benign cysts while confirming that the patient has an intratesticular tumor.
Blood tests measure tumor markers that help diagnose and stage the disease:
High AFP levels indicate the presence of components of a non-seminomatous tumor. Pure seminomas do not produce AFP.
Tumor markers aid in monitoring treatment effectiveness and detecting cancer recurrence.
This involves the surgical excision of the testicle via the inguinal route. It is used for diagnosis and treatment purposes.
The medical community avoids scrotal biopsy because it poses a risk of spreading cancerous tumors.
After orchiectomy, staging investigations include:
Staging helps determine whether the cancer has spread to the lymphatic system or other parts of the body, or is limited to the testicle.
There are three stages of testicular cancer that the medical community recognizes, and they are as follows:
The medical community uses risk classification systems to divide metastatic disease into three groups: good, intermediate, and poor.
The treatment plan should consider the tumor type (seminoma or non-seminoma), the current stage, and the patient's risk classification.
The majority of patients require radical inguinal orchiectomy as their initial surgical procedure.
However, in some cases of non-seminomas, RPLND can be done to remove the involved lymph nodes.
In patients who have Stage I tumors with low-risk characteristics, active surveillance is an option.
Surveillance includes:
This method prevents excessive treatment for patients who do not need it.
The primary treatment method for advanced disease cases uses chemotherapy as its main approach.
Common regimen:
The number of chemotherapy cycles that patients need depends on their current stage and risk classification.
Chemotherapy can effectively treat metastatic disease.
Radiation therapy treats early-stage seminomas that have spread to lymph nodes.
Doctors rarely use it as a treatment option for non-seminomatous tumors.
Surgical procedures become necessary for residual masses that persist after chemotherapy treatment of non-seminomatous tumors.
Patient's experience:
Doctors recommend sperm banking to patients who will undergo chemotherapy.
Most men who undergo a testicle removal procedure will maintain normal testosterone levels because their remaining testis will take over.
Patients need to preserve their sperm before treatment because their fertility will be restored after treatment.
Men can receive psychological counseling to help them with their concerns about masculinity and body image, together with reproductive health issues.
Testicular cancer ranks as one of the most treatable solid tumors that exists.
More than 95% of patients achieve successful treatment outcomes.
Combination chemotherapy leads to successful treatment results in patients who have advanced disease.
Patients with metastatic disease can expect positive treatment outcomes.
Over 90% of patients will survive for extended periods.
The first 2-3 years of patient treatment require particular emphasis on follow-up activities.
Includes
Most recurrences occur early and are treatable.
Tender Palm Super-Speciality Hospital offers advanced Testicular Cancer treatment in Lucknow, India, at an affordable cost. We have a team of experienced urological surgeons and oncology specialists who provide accurate diagnosis and both non-surgical and surgical treatment options including orchiectomy, chemotherapy, and radiation therapy. Our Urology and Oncology team has decades of experience in successfully treating Testicular Cancer in Lucknow, India.
Call us at +91-9076972161
Email at care@tenderpalm.com